Victoria Vakiener's Insider Trades & SAST Disclosures
Victoria Vakiener's most recent trade in Arrowhead Pharmaceuticals Inc. was a trade of 16,733 Common Stock done at an average price of $23.0 . Disclosure was reported to the exchange on Dec. 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Victoria Vakiener.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals ... | Vakiener Victoria | Director | Grant, award, or other acquisition of securities at price $ 22.99 per share. | 18 Dec 2024 | 16,733 | 37,944 (0%) | 0% | 23.0 | 384,692 | Common Stock |
| Arrowhead Pharmaceuticals ... | Victoria Vakiener | Director | Sale of securities on an exchange or to another person at price $ 21.91 per share. | 16 Dec 2024 | 8,994 | 21,211 (0%) | 0% | 21.9 | 197,059 | Common Stock |
| Chimerix Inc | Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Arrowhead Pharmaceuticals ... | Victoria Vakiener | Director | Sale of securities on an exchange or to another person at price $ 23.31 per share. | 02 May 2024 | 1,799 | 30,205 (0%) | 0% | 23.3 | 41,935 | Common Stock |
| Arrowhead Pharmaceuticals ... | Vakiener Victoria | Director | Sale of securities on an exchange or to another person at price $ 37.87 per share. | 11 Jan 2024 | 3,620 | 33,101 (0%) | 0% | 37.9 | 137,089 | Common Stock |
| Arrowhead Pharmaceuticals ... | Vakiener Victoria | Director | Sale of securities on an exchange or to another person at price $ 38.84 per share. | 11 Jan 2024 | 1,100 | 32,001 (0%) | 0% | 38.8 | 42,724 | Common Stock |
| Arrowhead Pharmaceuticals ... | Vakiener Victoria | Director | Grant, award, or other acquisition of securities at price $ 25.41 per share. | 15 Dec 2023 | 14,987 | 36,721 (0%) | 0% | 25.4 | 380,820 | Common Stock |
| Chimerix Inc | Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Arrowhead Pharmaceuticals ... | Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 7,867 | 23,284 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 4,593 | 4,593 | - | - | Common Stock | |
| Arrowhead Pharmaceuticals ... | Victoria Vakiener | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Jan 2023 | 1,764 | 15,417 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Victoria Vakiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges